RO60 and Alzheimer disease: On the other hand, patients with “idiopathic” rhythm disturbances should be considered for specific anti-Ro/SSA testing (iWB technique is recommended for detecting arrhythmogenic anti-Ro/SSA subtypes), regardless the presence or not of a manifest AD, given that the demonstration of circulating antibodies may lead to innovative therapeutic opportunities.